Skip to content

Clinical Study on Moxibustion for the Treatment of Chronic Nonspecific Low Back Pain

Construction of an Acupoint Sensory Transmission Moxibustion Therapy System Based on Zhou Meisheng's "Pathological Sensory Transmission of Moxibustion Sensation" Law and Clinical Study on Moxibustion for the Treatment of Chronic Nonspecific Low Back Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001296
Enrollment
Unknown
Registered
2025-06-27
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic nonspecific low back pain

Interventions

Moxibustion group:Moxibustion at the bilateral Shenshu (BL23)Yaoyangguan (GV3) and Jinsuo (GV8) acupoints with the moxibustion temperature maintained at 43 ± 1°C
Sham moxibustion group:Moxibustion at the bilateral Shenshu (BL23)Yaoyangguan (GV3) and Jinsuo (GV8) acupoints with the moxibustion temperature maintained at 37 ± 1°C

Sponsors

The Second Affiliated Hospital of Anhui University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the diagnostic criteria for chronic nonspecific low back pain (CNLBP); (2) Aged between 20 and 55 years with no gender restriction; (3) Scoring =3 on the Numeric Rating Scale (NRS) for pain; (4) Demonstrating good compliance and voluntarily signing the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Misdiagnosis; (2) History of lumbar trauma lumbar dislocation or prior lumbar surgery; (3) Presence of specific spinal or nerve root pathology on imaging studies such as spinal deformity fracture tumor or lumbar disc herniation compressing nerve roots; (4) Concomitant severe systemic diseases or psychiatric disorders; (5) Pregnant or lactating women; (6) Individuals with skin ulceration infection or allergy to moxibustion at the treatment site; (7) Those who have received relevant treatments affecting the study outcomes within the past 3 months; (8) Individuals currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
numerical rating scale;

Secondary

MeasureTime frame
Fear Avoidance Beliefs Questionnaire;36-Item Short Form Health Survey;Global Perceived Effect;Oswestry disability index; functional near-infrared spectroscopy;

Countries

China

Contacts

Public ContactZhu Caifeng

The Second Affiliated Hospital of Anhui University of Chinese Medicine

727687720@qq.com13956956764

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026